Professional Documents
Culture Documents
Prof. CB Choudhary
NMCTH
Prof. Dr. CB Choudhary
Pharmacology
NMCTH
Personalized Medicine
Is Medicine a science or an art?
The differences in response are most commonly due to variations in the amount of
metabolising enzymes. The production of these enzymes is genetically controlled.
Use of genetic information to guide the choice of drug & dose on an individual basis.
Intends to identify individuals who are either more likely or less likely to respond to a drug on
an individual basis.
Pharmacogenetics
1. The rate of drug acetylation differs among individuals
who may be fast or slow acetylators.E.g. INH ,
Sulfonamides & Hydralazine metabolized by
acetylation. The acetylator status of an individual
significantly affects the nature of adverse effects with
drugs which are mainly metabolized through acetylation.
– Slow acetylators treated with Hydralazine more likely to
develop lupus erythematosus.
– In slow acetylators INH get accumulated after repeated doses
leading to neurotoxicity.
– In fast acetylators INH metabolizes faster providing higher
concentration of metabolic product acetyl hydrazine causing
hepatotoxicity.
– Dapsone therapy in slow acetylators may lead to haemolysis.
2. Atypical pseudocholine esterase results in
prolonged succinylcholine apnoea. Some
people inherit an atypical pseudocholine
esterase which can not quickly metabolize
succinylcholine.
3. G6PD deficiency responsible for haemolysis with
Primaquine & other oxidizing drugs. This X-linked
monogenic trait is more common in the Mediterranean,
African & Southeast Asian races. Haemolysis largely dose
related.